Abstract
Interleukin 10 (IL-10) is a Th2 anti-inflammatory cytokine that participates in the regulation of the immune response at several levels. Its production has been implicated in the immunosuppression frequently observed in tumor bearing hosts. The broad spectrum of IL-10 biologic activities is mediated by its binding to its cognate receptor (IL-10R). We have already demonstrated the overproduction of IL-10 by B-cell lymphoma tumor bearing rats and, also, that IL-10 could act as a growth factor for metastatic cells. Considering the importance to unravel each feature of the complex biology of metastasis, the goal of the present study was to investigate the expression of IL-10 receptor (IL-10R), at mRNA and protein level, in primary tumor and metastatic cells from a rat B-cell lymphoma, along with the production of IL-10 by both tumor cell types. Our results indicate that IL-10, besides its immunoregulatory effect, would act as an autocrine growth factor for cells with metastatic phenotype. Also, the up-regulation of IL-10 and IL-10R expression would be part of the transition from primary tumor to the metastatic phenotype.
Similar content being viewed by others
References
MC Cohen S. Cohen (1996) ArticleTitleCytokine function. A study in biologic diversity Am J Clin Pathol 105 589–98 Occurrence Handle8623768
R Waal Malefyt ParticleDe J Haanen H Spits et al. (1991) ArticleTitleInterleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II Major Histocompatibility Complex expression J Exp Med 174 915–24 Occurrence Handle10.1084/jem.174.4.915 Occurrence Handle1655948
R Donnelly H Dickensheets D. Finbloom (1999) ArticleTitle The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes J Interferon Cytokine Res 19 563–73 Occurrence Handle10.1089/107999099313695 Occurrence Handle10433356
S Mocellin F Marincola CR Rossi et al. (2004) ArticleTitleThe multifaceted relationship between IL-10 and adaptative immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 61–76 Occurrence Handle10.1016/j.cytogfr.2003.11.001 Occurrence Handle14746814
L Ding P Linsley L Huang et al. (1993) ArticleTitleE. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression J Immunol 151 1224–34 Occurrence Handle7687627
M Howard A. O’Garra (1992) ArticleTitleBiological properties of interleukin 10 Immunol Today 13 IssueID6 198–200 Occurrence Handle10.1016/0167-5699(92)90153-X Occurrence Handle1385707
Q Chen V Daniel D Maher P. Hersey (1994) ArticleTitleProduction of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma Int J Cancer 56 755–60 Occurrence Handle8314354
S Chouaib C Asselin-Paturel F Mami-Chouaib et al. (1997) ArticleTitleThe host-tumor immune conflict: from immunosuppession to resistance and destruction Immunol Today 18 493–7 Occurrence Handle10.1016/S0167-5699(97)01115-8 Occurrence Handle9357142
G. Pawelec (1999) ArticleTitleTumour escape from the immune response the last hurdle for successful immunotherapy of cancer? Cancer Immunol Immunother 48 343–5 Occurrence Handle10.1007/s002620050584 Occurrence Handle10501845
P Matar VR Rozados AD González et al. (2000) ArticleTitleMechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide Eur J Cancer 36 1060–6 Occurrence Handle10.1016/S0959-8049(00)00044-7 Occurrence Handle10885612
P Matar VR Rozados SI Gervasoni OG. Scharovsky (2001) ArticleTitleDown regulation of T-Cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal proliferative response Int Immunopharmacol 1 307–19 Occurrence Handle10.1016/S1567-5769(00)00028-X Occurrence Handle11360931
P Matar VR Rozados SI Gervasoni OG. Scharovsky (2002) ArticleTitleTh2/Thl switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model Cancer Immunol Immunother 50 588–96 Occurrence Handle10.1007/s00262-001-0237-3 Occurrence Handle11807622
JY Blay N Burdin F Rousset et al. (1993) ArticleTitleSerum interleukin-10 in non-Hodgkin’s lymphoma a prognostic factor Blood 82 2169–74 Occurrence Handle8400266
H Ward S Vigues S Poole AF. Bristow (2001) ArticleTitleThe rat interleukin 10 receptor: cloning and sequencing of cDNA coding for the alpha-chain protein sequence, and demonstration by western blotting of expression in the rat brain Cytokine 15 237–40 Occurrence Handle10.1006/cyto.2001.0933 Occurrence Handle11594787
S Calderari MT Font O Garrocq et al. (1991) ArticleTitleThe inbred IIM/Fm stock Rat News Lett 25 28–9
Canadian Council on Animal Care Guide to the Care and Use of Experimental Animals Vol 1, 2nd edn, 1993
MT Font GC Celoria LI. Hinrichsen (1983) ArticleTitleGenetic analysis of tumor resistance in an inbred line of rats Medicina (B Aires) 43 502–8
KW Walker R Llul GK Balkian et al. (1992) ArticleTitleA rapid sensitive cellular enzyme-linked immunoadsorbent assay (CELISA) for the detection and quantitation of antibodies against cell surface determinants J Immunol Methods 154 121–30 Occurrence Handle10.1016/0022-1759(92)90219-J Occurrence Handle1401938
KJ Livak TD. Schmittgen (2001) ArticleTitle Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method Methods 25 402–8 Occurrence Handle10.1006/meth.2001.1262 Occurrence Handle11846609
JJ Sedmak SE. Grossberg (1977) ArticleTitle A rapid, sensitive and versatile assay for protein using Coomassie brilliant blue G250 Anal Biochem 79 544–52 Occurrence Handle10.1016/0003-2697(77)90428-6 Occurrence Handle68686
UK. Laemmli (1970) ArticleTitle Cleavage of structural protein during the assembly of the head of bacteriophage T4 Nature 227 680–5 Occurrence Handle5432063
R. Welch Danny (2003) ArticleTitle Metastasis regulatory genes Sci Med 9 202–13
R Kiessling K Wasserman S Horiguchi et al. (1999) ArticleTitleTumor-induced immune dysfunction Cancer Immunol Immunother 48 353–62 Occurrence Handle10.1007/s002620050586 Occurrence Handle10501847
RD Bonfil GA López R Fridman (2002) Biología de la invasión y las metastasis RD Bonfil OG Scharovsky (Eds) Oncología Molecular y Celular Editorial Dunken Buenos Aires 245–64
E. Gilboa (1999) ArticleTitle How tumors escape immune destruction and what we can do about it Cancer Immunol Immunother 48 382–5 Occurrence Handle10.1007/s002620050590 Occurrence Handle10501851
TR Mosmann RL. Coffman (1989) ArticleTitle Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties Ann Rev Immunol 7 145–73 Occurrence Handle10.1146/annurev.iy.07.040189.001045
H Bohlen M Kessler M Sextro et al. (2000) ArticleTitlePoor clinical outcome of patients with Hodgkin’s disease and elevated interleukin-10 serum levels Ann Hematol 79 110–3 Occurrence Handle10.1007/s002770050564 Occurrence Handle10803931
J Kim RL Modlin RL Moy et al. (1995) ArticleTitleIL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response J Immunol 155 2240–7 Occurrence Handle7636270
FY Yue R Dummer R Geertsen et al. (1997) ArticleTitleInterleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-I molecules Int J Cancer 71 630–7 Occurrence Handle10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E Occurrence Handle9178819
M Kobayashi H Kobayashi RB Pollard F. Suzuki (1998) ArticleTitleA pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma J Immunol 160 5869–73 Occurrence Handle9637498
F Vita ParticleDe M Orditura G Galizia et al. (2000) ArticleTitleSerum interleukin-10 levels as a prognostic factor’ in advanced non-small cell lung cancer patients Chest 117 365–73 Occurrence Handle10.1378/chest.117.2.365 Occurrence Handle10669676
M Huang J Wang P Lee et al. (1995) ArticleTitleHuman non-small cell lung cancer express a type 2 cytokine pattern Cancer Res 55 3847–53 Occurrence Handle7641203
GL. Nicolson (1993) ArticleTitle Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis Exp Cell Res 204 171–80 Occurrence Handle10.1006/excr.1993.1022 Occurrence Handle8382620
IJ Fidler (1997) Molecular biology of cancer. Invasion and metastasis F Vita ParticleDe T Vincent S Hellman SA Rosenberg (Eds) Cancer Principles and Practice of Oncology EditionNumber5 Lippincott-Raven Publishers Philadelphia 121–34
O Nyormoi M. Bar-Eli (2003) ArticleTitle Transcriptional regulation of metastasis-related genes in human melanoma Clin Exp Metastasis 30 251–63 Occurrence Handle10.1023/A:1022991302172
M Salerno T Ouatas D Palmieri PS. Steeg (2003) ArticleTitle Inhibition of signal transduction by nm23 metastasis suppressor: possible mechanisms Clin Exp Metastasis 20 3–10 Occurrence Handle10.1023/A:1022578000022 Occurrence Handle12650601
J Hamada PG Cavanaugh O Lotan GL. Nicolson (1992) ArticleTitle Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endotelial cells derived from target organs for metastasis Br J Cancer 6 349–54
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rico, M.J., Matar, P., Gervasoni, S.I. et al. The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretion. Clin Exp Metastasis 22, 127–135 (2005). https://doi.org/10.1007/s10585-005-5140-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10585-005-5140-4